Journal Article10.1016/j.jtho.2022.07.006
2021 WHO Classification of Lung Cancer: A Globally Applicable and Molecular Biomarker-Relevant Classification.
12
About: This article is published in Journal of Thoracic Oncology. The article was published on 01 Sep 2022. The article focuses on the topics: Medicine & Lung cancer.
read more
Chat with Paper
AI Agents for this Paper
Find similar papers on Google Scholar, PubMed and Arxiv
Write a critical review of this paper
Analyze citations of this paper to find unaddressed research gaps
Citations
Inhalable nanoparticles with enhanced cuproptosis and cGAS–STING activation for synergistic lung metastasis immunotherapy
Chongzheng Yan,Huaiyou Lv,Yuanming Feng,Yong Li,Zhongxi Zhao +4 more
TL;DR: Inhalable nanoparticles with enhanced cuproptosis and cGAS–STING activation for synergistic lung metastasis immunotherapy enhance cuproptosis and activate STING pathway, leading to potent antitumor immunity.
6
Combined time-restricted feeding and cisplatin enhance the anti-tumor effects in cisplatin-resistant and -sensitive lung cancer cells
Jianling Li,Dan Shi,Xuemei Lian +2 more
TL;DR: In this article , concomitant treatment with time-restricted feeding (TRF) plus cisplatin (DDP) was investigated in DDP-resistant and DDPsensitive lung cancer cells.
Integrative Analysis of Single-Cell and Bulk RNA Sequencing Reveals Prognostic Characteristics of Macrophage Polarization-Related Genes in Lung Adenocarcinoma
Ke Mi,Lizhong Zeng,Yan Chen,Shuanying Yang +3 more
TL;DR: A prognostic risk model for LUAD patients was constructed by univariate Cox and Least Absolute Shrinkage and Selection Operator (LASSO), and qPCR confirmed that the expression of the prognosis genes was generally consistent with the results of the bioinformatic analysis.
2
Brief report: Reclassifying SCLC-Y as SMARCA4 deficient malignancies - resolving the controversy
Jin Ng,Ling Cai,Luc Girard,Owen W.J. Prall,Neeha Rajan,Christine Khoo,Ahida Batrouney,Ariena Kersbergen,Michael Christ,John D. Minna,Marian L. Burr,Kate D. Sutherland +11 more
TL;DR: A detailed molecular and histological characterisation of YAP1 expressing SCLC-Y is undertaken to understand the biology of this proposed subtype and suggests that, unlike ASCL1, NEUROD1 and POU2F3, YAP 1 is not a subtype defining transcription factor in SCLc.
Towards a clinically applicable histomolecular classification of lung adenocarcinomas?
TL;DR: In this paper , DNA methylation profiling identifies subgroups of lung Adenocarcinoma with distinct immune cell composition, DNA Methylation Age, and Clinical Outcome, and identifies subgroup of lung cancer.
References
Cancer statistics, 2022
TL;DR: Progress has stagnated for breast and prostate cancers but strengthened for lung cancer, coinciding with changes in medical practice related to cancer screening and/or treatment, and mortality patterns reflect incidence trends.
16K
International Association for the Study of Lung Cancer/American Thoracic Society/European Respiratory Society International Multidisciplinary Classification of Lung Adenocarcinoma
William D. Travis,Elisabeth Brambilla,Masayuki Noguchi,Andrew G. Nicholson,Kim R. Geisinger,Yasushi Yatabe,David G. Beer,Charles A. Powell,Gregory J. Riely,Paul Van Schil,Kavita Garg,John H. M. Austin,Hisao Asamura,Valerie W. Rusch,Fred R. Hirsch,Giorgio V. Scagliotti,Tetsuya Mitsudomi,Rudolf M. Huber,Yuichi Ishikawa,James R. Jett,Montserrat Sanchez-Cespedes,Jean-Paul Sculier,Takashi Takahashi,Masahiro Tsuboi,Johan Vansteenkiste,Ignacio I. Wistuba,Pan-Chyr Yang,Denise R. Aberle,Christian Brambilla,Douglas B. Flieder,Wilbur A. Franklin,Adi F. Gazdar,Michael K. Gould,Philip S. Hasleton,Douglas W. Henderson,Bruce E. Johnson,David A Johnson,Keith M. Kerr,Keiko Kuriyama,Jin Soo Lee,Vincent A. Miller,Iver Petersen,Victor L. Roggli,Rafael Rosell,Nagahiro Saijo,Erik Thunnissen,M. Tsao,David Yankelewitz +47 more
TL;DR: This new adenocarcinoma classification is needed to provide uniform terminology and diagnostic criteria, especially for bronchioloalveolar carcinoma (BAC), the overall approach to small nonresection cancer specimens, and for multidisciplinary strategic management of tissue for molecular and immunohistochemical studies.
4.6K
The 5th edition of the World Health Organization Classification of Haematolymphoid Tumours: Myeloid and Histiocytic/Dendritic Neoplasms
Joseph D. Khoury,Eric Solary,Oussama Abla,Yassmine Akkari,Rita Alaggio,Jane F. Apperley,Rafael Bejar,Emilio Berti,Lambert Busque,John K.C. Chan,Weina Chen,Xi Chen,Wee Joo Chng,John K. Choi,Isabel Colmenero,Sarah E. Coupland,Nicholas C.P. Cross,Daphne de Jong,M. Tarek Elghetany,Emiko Takahashi,Jean-François Emile,Judith A. Ferry,Linda Fogelstrand,Michaela Fontenay,Ulrich Germing,Sumeet Gujral,Torsten Haferlach,Claire N. Harrison,Jennelle C. Hodge,Shimin Hu,Joop H. Jansen,Rashmi Kanagal-Shamanna,Hagop M. Kantarjian,Christian P. Kratz,Xiao-Qiu Li,Megan S. Lim,Keith R. Loeb,Sanam Loghavi,Andrea N. Marcogliese,Soheil Meshinchi,Phillip Michaels,Kikkeri N. Naresh,Yasodha Natkunam,Reza Nejati,German Ott,Eric Padron,Keyur Patel,Nikhil Patkar,Jennifer Picarsic,Uwe Platzbecker,Irene Roberts,Anna Schuh,William C. Sewell,Reiner Siebert,Prashant Tembhare,Jeffrey W. Tyner,Srdan Verstovsek,Wei Wang,Brent L. Wood,W Q Xiao,Cecilia Yeung,Andreas Hochhaus +61 more
TL;DR: The 5th edition of the World Health Organization (WHO) Classification of Haematolymphoid Tumours is part of an effort to hierarchically catalogue human cancers arising in various organ systems within a single relational database as discussed by the authors .
•Book
Pathology and genetics of tumours of the lung , pleura, thymus and heart
William D. Travis
- 20 Sep 2004
TL;DR: This book will not become a unity of the way for you to get amazing benefits at all, but, it will serve something that will let you get the best time and moment to spend for reading the book.
2.3K